Ragweed Allergy - Pipeline Review, H2 2016 - Global Markets Direct - Market Research

Ragweed Allergy - Pipeline Review, H2 2016

Ragweed Allergy - Pipeline Review, H2 2016 - Global Markets Direct - Market Research
Ragweed Allergy - Pipeline Review, H2 2016
Published Jul 13, 2016
37 pages — Published Jul 13, 2016
Price US$ 2,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Ragweed Allergy - Pipeline Review, H2 2016, provides an overview of the Ragweed Allergy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ragweed Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ragweed Allergy and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Ragweed Allergy
- The report reviews pipeline therapeutics for Ragweed Allergy by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Ragweed Allergy therapeutics and enlists all their major and minor projects
- The report assesses Ragweed Allergy therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Ragweed Allergy

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Ragweed Allergy
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Ragweed Allergy pipeline depth and focus of Indication therapeutics
-

  
Source:
Document ID
GMDHC8230IDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables41
  List of Figures41
Introduction51
  Global Markets Direct Report Coverage51
Ragweed Allergy Overview61
Therapeutics Development71
  Pipeline Products for Ragweed Allergy Overview71
Ragweed Allergy Therapeutics under Development by Companies81
Ragweed Allergy Pipeline Products Glance93
  Clinical Stage Products91
  Early Stage Products101
  Unknown Stage Products111
Ragweed Allergy Products under Development by Companies121
Ragweed Allergy Companies Involved in Therapeutics Development134
  Anergis SA131
  Biomay AG141
  Circassia Pharmaceuticals Plc151
  Immunomic Therapeutics, Inc.161
Ragweed Allergy Therapeutics Assessment176
  Assessment by Monotherapy Products171
  Assessment by Target181
  Assessment by Route of Administration192
  Assessment by Molecule Type212
Drug Profiles237
  AllerR Drug Profile232
  BM-34 Drug Profile251
  Multi-LAMP-Vax Drug Profile261
  PL-101 Drug Profile271
  Vaccine for Asthma and Ragweed-Induced Rhinoconjunctivitis Drug Profile282
Ragweed Allergy Dormant Projects301
Ragweed Allergy Discontinued Products311
Ragweed Allergy Product Development Milestones324
  Featured News &Press Releases321
    Dec 19, 2014: Anergis Granted U.S. Patent for Ragweed Allergy Vaccine AllerR321
    Dec 08, 2014: Circassia Announces Top-Line Results from Ragweed Allergy Treatment Phase IIb Chamber Study321
    Feb 21, 2013: Anergis To Present Preclinical Data On Ragweed Allergy Vaccine Candidate AllerR At AAAAI 2013 Annual Meeting331
    Jun 14, 2012: Anergis Reaches Several Preclinical Development Milestones With Ragweed Pollen Vaccine341
    Mar 07, 2012: Circassia s Ragweed Allergy Therapy Achieves Positive Phase II Clinical Results351
    Jan 19, 2012: Circassia Receives European Patent For Its Ragweed Allergy T-Cell Vaccine351
Appendix362
  Methodology361
  Coverage361
  Secondary Research361
  Primary Research361
  Expert Panel Validation361
  Contact Us361
  Disclaimer371

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Ragweed Allergy - Pipeline Review, H2 2016" Jul 13, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Ragweed-Allergy-Pipeline-Review-H2-2016-2088-16163>
  
APA:
Global Markets Direct - Market Research. (2016). Ragweed Allergy - Pipeline Review, H2 2016 Jul 13, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Ragweed-Allergy-Pipeline-Review-H2-2016-2088-16163>
  
US$ 2,000.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.